Suraksha Diagnostic Limited — Updates, 05-02-2026: Press Release
05-02-2026 | 05:22 pm
05-02-2026 | 05:22 pm
Suraksha Diagnostic's Q3 FY26 revenue jumped 30.3% to ₹78.31 Cr, with EBITDA up 26.1% to ₹23.78 Cr and PAT rising 21% to ₹7.24 Cr. Strong growth driven by network expansion and 30.7% higher test volumes. The company launched a new genomics vertical.
No comments yet. Be the first to comment!
